These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23580156)

  • 21. Immunogenic cell death after combined treatment with radiation and ATR inhibitors is dually regulated by apoptotic caspases.
    Eek Mariampillai A; Hauge S; Kongsrud K; Syljuåsen RG
    Front Immunol; 2023; 14():1138920. PubMed ID: 37346039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients.
    Fucikova J; Truxova I; Hensler M; Becht E; Kasikova L; Moserova I; Vosahlikova S; Klouckova J; Church SE; Cremer I; Kepp O; Kroemer G; Galluzzi L; Salek C; Spisek R
    Blood; 2016 Dec; 128(26):3113-3124. PubMed ID: 27802968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of immunogenic cell death and enhancement of the radiation-induced immunogenicity by chrysin in melanoma cancer cells.
    Jafari S; Ardakan AK; Aghdam EM; Mesbahi A; Montazersaheb S; Molavi O
    Sci Rep; 2024 Oct; 14(1):23231. PubMed ID: 39369019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Withania somnifera Induces Cytotoxic and Cytostatic Effects on Human T Leukemia Cells.
    Turrini E; Calcabrini C; Sestili P; Catanzaro E; de Gianni E; Diaz AR; Hrelia P; Tacchini M; Guerrini A; Canonico B; Papa S; Valdrè G; Fimognari C
    Toxins (Basel); 2016 May; 8(5):. PubMed ID: 27187469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation.
    Garg AD; Nowis D; Golab J; Vandenabeele P; Krysko DV; Agostinis P
    Biochim Biophys Acta; 2010 Jan; 1805(1):53-71. PubMed ID: 19720113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autophagy activation by dietary piceatannol enhances the efficacy of immunogenic chemotherapy.
    Wang S; Wang G; Wu W; Xu Z; Yang J; Cao M; Wang Q; Wang J; Yang C; Zhang W
    Front Immunol; 2022; 13():968686. PubMed ID: 35979349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanisms of ATP secretion during immunogenic cell death.
    Martins I; Wang Y; Michaud M; Ma Y; Sukkurwala AQ; Shen S; Kepp O; Métivier D; Galluzzi L; Perfettini JL; Zitvogel L; Kroemer G
    Cell Death Differ; 2014 Jan; 21(1):79-91. PubMed ID: 23852373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells.
    Jafari S; Lavasanifar A; Hejazi MS; Maleki-Dizaji N; Mesgari M; Molavi O
    Daru; 2020 Jun; 28(1):159-169. PubMed ID: 31942696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Light activation of iridium(III) complexes driving ROS production and DNA damage enhances anticancer activity in A549 cells.
    Li W; Shi C; Wu X; Zhang Y; Liu H; Wang X; Huang C; Liang L; Liu Y
    J Inorg Biochem; 2022 Nov; 236():111977. PubMed ID: 36030672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bullatacin triggers immunogenic cell death of colon cancer cells by activating endoplasmic reticulum chaperones.
    Fan F; Shen P; Ma Y; Ma W; Wu H; Liu H; An Q
    J Inflamm (Lond); 2021 Jun; 18(1):23. PubMed ID: 34112202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death.
    Hodge JW; Garnett CT; Farsaci B; Palena C; Tsang KY; Ferrone S; Gameiro SR
    Int J Cancer; 2013 Aug; 133(3):624-36. PubMed ID: 23364915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consensus guidelines for the detection of immunogenic cell death.
    Kepp O; Senovilla L; Vitale I; Vacchelli E; Adjemian S; Agostinis P; Apetoh L; Aranda F; Barnaba V; Bloy N; Bracci L; Breckpot K; Brough D; Buqué A; Castro MG; Cirone M; Colombo MI; Cremer I; Demaria S; Dini L; Eliopoulos AG; Faggioni A; Formenti SC; Fučíková J; Gabriele L; Gaipl US; Galon J; Garg A; Ghiringhelli F; Giese NA; Guo ZS; Hemminki A; Herrmann M; Hodge JW; Holdenrieder S; Honeychurch J; Hu HM; Huang X; Illidge TM; Kono K; Korbelik M; Krysko DV; Loi S; Lowenstein PR; Lugli E; Ma Y; Madeo F; Manfredi AA; Martins I; Mavilio D; Menger L; Merendino N; Michaud M; Mignot G; Mossman KL; Multhoff G; Oehler R; Palombo F; Panaretakis T; Pol J; Proietti E; Ricci JE; Riganti C; Rovere-Querini P; Rubartelli A; Sistigu A; Smyth MJ; Sonnemann J; Spisek R; Stagg J; Sukkurwala AQ; Tartour E; Thorburn A; Thorne SH; Vandenabeele P; Velotti F; Workenhe ST; Yang H; Zong WX; Zitvogel L; Kroemer G; Galluzzi L
    Oncoimmunology; 2014 Oct; 3(9):e955691. PubMed ID: 25941621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death.
    Zappasodi R; Pupa SM; Ghedini GC; Bongarzone I; Magni M; Cabras AD; Colombo MP; Carlo-Stella C; Gianni AM; Di Nicola M
    Cancer Res; 2010 Nov; 70(22):9062-72. PubMed ID: 20884630
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Araki K; Yamamuro N; Tomonobu N; Kumon H
    Anticancer Res; 2021 Oct; 41(10):4837-4855. PubMed ID: 34593432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer.
    Angelova AL; Grekova SP; Heller A; Kuhlmann O; Soyka E; Giese T; Aprahamian M; Bour G; Rüffer S; Cziepluch C; Daeffler L; Rommelaere J; Werner J; Raykov Z; Giese NA
    J Virol; 2014 May; 88(10):5263-76. PubMed ID: 24574398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenic Apoptotic Cell Death and Anticancer Immunity.
    Vandenabeele P; Vandecasteele K; Bachert C; Krysko O; Krysko DV
    Adv Exp Med Biol; 2016; 930():133-49. PubMed ID: 27558820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth.
    Rodríguez-Salazar MDC; Franco-Molina MA; Mendoza-Gamboa E; Martínez-Torres AC; Zapata-Benavides P; López-González JS; Coronado-Cerda EE; Alcocer-González JM; Tamez-Guerra RS; Rodríguez-Padilla C
    Oncol Lett; 2017 Jul; 14(1):844-852. PubMed ID: 28693241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dinaciclib induces immunogenic cell death and enhances anti-PD1-mediated tumor suppression.
    Hossain DMS; Javaid S; Cai M; Zhang C; Sawant A; Hinton M; Sathe M; Grein J; Blumenschein W; Pinheiro EM; Chackerian A
    J Clin Invest; 2018 Feb; 128(2):644-654. PubMed ID: 29337311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulation of dendritic cells by DAMPs in ALA-PDT treated SCC tumor cells.
    Wang X; Ji J; Zhang H; Fan Z; Zhang L; Shi L; Zhou F; Chen WR; Wang H; Wang X
    Oncotarget; 2015 Dec; 6(42):44688-702. PubMed ID: 26625309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An optimized retinoic acid-inducible gene I agonist M8 induces immunogenic cell death markers in human cancer cells and dendritic cell activation.
    Castiello L; Zevini A; Vulpis E; Muscolini M; Ferrari M; Palermo E; Peruzzi G; Krapp C; Jakobsen M; Olagnier D; Zingoni A; Santoni A; Hiscott J
    Cancer Immunol Immunother; 2019 Sep; 68(9):1479-1492. PubMed ID: 31463653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.